Titan Pharmaceutical, a company that sells the drug and its derivatives for treating chronic pain, said Tuesday it has filed a registration statement with the Securities and Exchange Commission.Titan has received approval to market the drug in the United States, Europe and Canada, it said in a statement.Titans sales are up 28 percent in the […]

Continue Reading...